Article Details

Zacks: Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) Given Consensus Rating of “Strong Buy ...

Retrieved on: 2020-01-04 05:22:30

Tags for this article:

Click the tags to see associated articles and topics

Zacks: Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) Given Consensus Rating of “Strong Buy .... View article details on hiswai:

Excerpt

<div><b>Renaissance Technologies</b> LLC raised its holdings in shares of Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) by 82.5% in the 2nd quarter, ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo